ProShare Advisors’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$106K Sell
19,355
-805
-4% -$4.4K ﹤0.01% 1871
2025
Q1
$127K Sell
20,160
-525
-3% -$3.3K ﹤0.01% 1786
2024
Q4
$85.2K Buy
20,685
+9,589
+86% +$39.5K ﹤0.01% 2102
2024
Q3
$37.1K Buy
+11,096
New +$37.1K ﹤0.01% 2010